Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>TENNOR THERAP-B (06872.HK) Starts IPO Today; Entry Fee HKD3,823.17; WUXI APPTEC Joins Early-stage Investment
Recommend 13 Positive 17 Negative 6 |
||||
|
||||
|
TENNOR THERAP-B (06872.HK), a biotechnology company approaching commercialization, announced details of its IPO, proposing a global offering of 8.2806 million H shares, of which around 10% will be offered in Hong Kong and around 90% internationally. The offer price is HKD75.7 per share. Based on a board lot of 50 shares, the entry fee per lot is approximately HKD3,823.17. The stock starts its public offering today (14th) and will close at noon next Tuesday (19th), with listing expected next Friday (22nd). Joint sponsors are CITIC Securities and ABCI. The IPO attracted five cornerstone investors, including AMR Action Fund, L.P., AMR Action Fund, and SCSp, subscribing for shares equivalent to approximately USD29.8 million (approximately HKD234 million) in aggregate. WUXI APPTEC (02359.HK) is a long-standing investor of the company. Upon completion of the global offering, WUXI APPTEC will hold approximately 5.5% of the company's total issued share capital through WuXi Fund. The company expected to raise net proceeds of approximately HKD558 million from the listing. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
